{"pmid":32339089,"title":"Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis.","text":["Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis.","Viral Immunol","Silva Junior, Jose Valter Joaquim","Lopes, Thaisa Regina Rocha","de Oliveira, Pablo Sebastian Britto","Weiblen, Rudi","Flores, Eduardo Furtado","32339089"],"journal":"Viral Immunol","authors":["Silva Junior, Jose Valter Joaquim","Lopes, Thaisa Regina Rocha","de Oliveira, Pablo Sebastian Britto","Weiblen, Rudi","Flores, Eduardo Furtado"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339089","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1089/vim.2020.0059","topics":["Mechanism"],"weight":1,"_version_":1665264685445808128,"score":8.574329,"similar":[{"pmid":32113704,"pmcid":"PMC7127067","title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.","text":["The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.","Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease.","J Autoimmun","Rothan, Hussin A","Byrareddy, Siddappa N","32113704"],"abstract":["Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease."],"journal":"J Autoimmun","authors":["Rothan, Hussin A","Byrareddy, Siddappa N"],"date":"2020-03-02T11:00:00Z","year":2020,"_id":"32113704","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.jaut.2020.102433","keywords":["covid-19","coronavirus","pathogenesis","pneumonia","wuhan city"],"source":"PubMed","topics":["Transmission","Mechanism","Treatment","Diagnosis","Prevention"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875068653568,"score":57.785717},{"pmid":32322401,"pmcid":"PMC7171518","title":"Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).","text":["Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).","The coronavirus disease (COVID-19) is highly pathogenic viral infection caused by SARS-CoV-2. Currently, COVID-19 has caused global health concern. It is assumed that COVID-19 has zoonotic origin based on the large number of infected people who were exposed to the wet market in Wuhan City, China. The phylogenetic analysis has revealed that SARS-CoV-2 has significant sequence similarity with severe acute respiratory syndrome-like (SARS-like) bat viruses, thus bats could be primary possible reservoir. The intermediate host and there subsequent transfer is not known yet, although human to human transfer is widely confirmed. The transmission of COVID-19 infection from one person to another resulted in the isolation of patients who were subsequently given a variety of treatments. To monitor the current outbreak, robust steps have been taken around the globe to reduce the transmission of COVID-19 infection particularly banning international and domestic flights, inducting lockdowns in vulnerable areas, social distancing etc. No clinically approved antiviral drug or vaccine against COVID-19 is reported yet. However, in clinical trials, few broad-spectrum antiviral drugs were evaluated against COVID-19 infection which resulted in clinical recovery. In this article emergence and pathogenicity of COVID-19 infection along with potential therapeutic strategies are analyzed to combat the COVID-19 pandemic.","New Microbes New Infect","Hamid, Saima","Mir, Mohammad Yaseen","Rohela, Gulab Khan","32322401"],"abstract":["The coronavirus disease (COVID-19) is highly pathogenic viral infection caused by SARS-CoV-2. Currently, COVID-19 has caused global health concern. It is assumed that COVID-19 has zoonotic origin based on the large number of infected people who were exposed to the wet market in Wuhan City, China. The phylogenetic analysis has revealed that SARS-CoV-2 has significant sequence similarity with severe acute respiratory syndrome-like (SARS-like) bat viruses, thus bats could be primary possible reservoir. The intermediate host and there subsequent transfer is not known yet, although human to human transfer is widely confirmed. The transmission of COVID-19 infection from one person to another resulted in the isolation of patients who were subsequently given a variety of treatments. To monitor the current outbreak, robust steps have been taken around the globe to reduce the transmission of COVID-19 infection particularly banning international and domestic flights, inducting lockdowns in vulnerable areas, social distancing etc. No clinically approved antiviral drug or vaccine against COVID-19 is reported yet. However, in clinical trials, few broad-spectrum antiviral drugs were evaluated against COVID-19 infection which resulted in clinical recovery. In this article emergence and pathogenicity of COVID-19 infection along with potential therapeutic strategies are analyzed to combat the COVID-19 pandemic."],"journal":"New Microbes New Infect","authors":["Hamid, Saima","Mir, Mohammad Yaseen","Rohela, Gulab Khan"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322401","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.nmni.2020.100679","keywords":["covid-19","pathogenesis","phylogenetic analysis","therapeutic strategies","transmission"],"source":"PubMed","topics":["Prevention","Mechanism","Treatment"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664895932628467712,"score":52.285458},{"pmid":31967327,"title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis.","text":["Emerging coronaviruses: Genome structure, replication, and pathogenesis.","The recent emergence of a novel coronavirus (2019-nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats.","J Med Virol","Chen, Yu","Liu, Qianyun","Guo, Deyin","31967327"],"abstract":["The recent emergence of a novel coronavirus (2019-nCoV), which is causing an outbreak of unusual viral pneumonia in patients in Wuhan, a central city in China, is another warning of the risk of CoVs posed to public health. In this minireview, we provide a brief introduction of the general features of CoVs and describe diseases caused by different CoVs in humans and animals. This review will help understand the biology and potential risk of CoVs that exist in richness in wildlife such as bats."],"journal":"J Med Virol","authors":["Chen, Yu","Liu, Qianyun","Guo, Deyin"],"date":"2020-01-23T11:00:00Z","year":2020,"_id":"31967327","week":"20204|Jan 20 - Jan 26","doi":"10.1002/jmv.25681","keywords":["coronavirus","epidemiology","pathogenesis","respiratory tract","virus classification","zoonoses"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875424120836,"score":52.021946},{"pmid":32283152,"title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.","text":["The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.","Cytokine storm is an excessive immune response to external stimuli. The pathogenesis of the cytokine storm is complex. The disease progresses rapidly, and the mortality is high. Certain evidence shows that, during the coronavirus disease 2019 (COVID-19) epidemic, the severe deterioration of some patients has been closely related to the cytokine storm in their bodies. This article reviews the occurrence mechanism and treatment strategies of the COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment.","J Infect","Ye, Qing","Wang, Bili","Mao, Jianhua","32283152"],"abstract":["Cytokine storm is an excessive immune response to external stimuli. The pathogenesis of the cytokine storm is complex. The disease progresses rapidly, and the mortality is high. Certain evidence shows that, during the coronavirus disease 2019 (COVID-19) epidemic, the severe deterioration of some patients has been closely related to the cytokine storm in their bodies. This article reviews the occurrence mechanism and treatment strategies of the COVID-19 virus-induced inflammatory storm in attempt to provide valuable medication guidance for clinical treatment."],"journal":"J Infect","authors":["Ye, Qing","Wang, Bili","Mao, Jianhua"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283152","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jinf.2020.03.037","keywords":["2019-ncov","coronavirus","cytokine storm","immunomodulation","sars-cov-2"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"locations":["Cytokine"],"_version_":1664636703978029057,"score":51.42237},{"pmid":32269085,"pmcid":"PMC7144260","title":"Pathogenesis of COVID-19 from a cell biology perspective.","text":["Pathogenesis of COVID-19 from a cell biology perspective.","Eur Respir J","Mason, Robert J","32269085"],"journal":"Eur Respir J","authors":["Mason, Robert J"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269085","week":"202015|Apr 06 - Apr 12","doi":"10.1183/13993003.00607-2020","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664637315647012865,"score":51.42237}]}